Anixa Biosciences Overview

Anixa Biosciences Research & Development

Research & Development expenses for ANIX.

Quarterly R&D Expenses

$1.26M

↓ 4.84% YoY

As of Apr 30, 2026

Annual R&D Expenses (TTM)

$4.56M

↓ 27.38% YoY

Trailing 12 months ending Apr 30, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin